KalVista Pharmaceuticals Changes Fiscal Year End
Ticker: KALV · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1348911
| Field | Detail |
|---|---|
| Company | Kalvista Pharmaceuticals, Inc. (KALV) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: fiscal-year-change, reporting
Related Tickers: KALV
TL;DR
KalVista just changed its fiscal year end to March 13, affecting reporting dates.
AI Summary
KalVista Pharmaceuticals, Inc. filed an 8-K on March 17, 2025, reporting a change in its fiscal year end from April 30 to March 13, effective March 13, 2025. This change impacts the company's reporting periods for financial statements and other regulatory filings.
Why It Matters
This change in fiscal year end will alter the timing of KalVista's financial reporting, potentially affecting investor analysis and comparisons with other companies.
Risk Assessment
Risk Level: low — The filing is a routine administrative change regarding fiscal year end and does not involve any new financial or operational risks.
Key Players & Entities
- KalVista Pharmaceuticals, Inc. (company) — Registrant
- March 13, 2025 (date) — Effective date of fiscal year change
- March 17, 2025 (date) — Filing date of the 8-K
- April 30 (date) — Previous fiscal year end
FAQ
What is the new fiscal year end for KalVista Pharmaceuticals?
The new fiscal year end for KalVista Pharmaceuticals is March 13, effective March 13, 2025.
When was this change reported to the SEC?
This change was reported via an 8-K filing on March 17, 2025.
What was the previous fiscal year end?
The previous fiscal year end was April 30.
What type of SEC filing is this?
This is a Form 8-K, a Current Report.
What is the primary reason for this 8-K filing?
The primary reason for this 8-K filing is to report an amendment to the company's articles of incorporation or bylaws related to the change in its fiscal year.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding KalVista Pharmaceuticals, Inc. (KALV).